| Sep 16, 2025 |
Sep 18, 2025 |
Y-mAbs Therapeutics, Inc.
|
Director |
Sell |
35.0
|
-4,590,138
|
-100.00%
|
✗
|
$39.3M |
| Dec 11, 2023 |
Dec 12, 2023 |
Y-mAbs Therapeutics, Inc.
|
Director |
Buy |
56.3
|
+6,455
|
0.14%
|
✗
|
$44.2K |
| Dec 7, 2023 |
Dec 11, 2023 |
Y-mAbs Therapeutics, Inc.
|
Director |
Buy |
90.0
|
+127,549
|
2.88%
|
✗
|
$890.4K |
| Nov 29, 2023 |
Dec 1, 2023 |
Y-mAbs Therapeutics, Inc.
|
Director |
Buy |
85.0
|
+51,837
|
1.19%
|
✗
|
$309.5K |
| Nov 27, 2023 |
Nov 29, 2023 |
Y-mAbs Therapeutics, Inc.
|
Director |
Buy |
85.0
|
+93,187
|
2.18%
|
✗
|
$521.3K |
| May 15, 2023 |
May 17, 2023 |
Y-mAbs Therapeutics, Inc.
|
Director |
Buy |
85.0
|
+101,740
|
2.43%
|
✗
|
$981.4K |
| Jun 10, 2021 |
Jun 11, 2021 |
Y-mAbs Therapeutics, Inc.
|
Director |
Sell |
37.5
|
-11,229
|
-0.27%
|
✗
|
$406K |
| Jun 8, 2021 |
Jun 10, 2021 |
Y-mAbs Therapeutics, Inc.
|
Director |
Sell |
16.3
|
-150,000
|
-3.46%
|
✗
|
$5.4M |
| Jun 7, 2021 |
Jun 9, 2021 |
Y-mAbs Therapeutics, Inc.
|
Director |
Sell |
17.5
|
-72,400
|
-1.64%
|
✗
|
$2.5M |
| Jun 3, 2021 |
Jun 7, 2021 |
Y-mAbs Therapeutics, Inc.
|
Director |
Sell |
27.5
|
-34,507
|
-0.78%
|
✗
|
$1.1M |
| May 28, 2021 |
Jun 2, 2021 |
Y-mAbs Therapeutics, Inc.
|
Director |
Sell |
27.5
|
-31,864
|
-0.71%
|
✗
|
$1.2M |
| Sep 5, 2019 |
Sep 9, 2019 |
Y-mAbs Therapeutics, Inc.
|
Director |
Sell |
37.5
|
-17,243
|
-0.31%
|
✗
|
$465.6K |
| Aug 29, 2019 |
Sep 3, 2019 |
Y-mAbs Therapeutics, Inc.
|
Director |
Sell |
17.5
|
-89,166
|
-1.59%
|
✗
|
$2.4M |
| Aug 27, 2019 |
Aug 29, 2019 |
Y-mAbs Therapeutics, Inc.
|
Director |
Sell |
27.5
|
-49,357
|
-0.87%
|
✗
|
$1.3M |
| Aug 22, 2019 |
Aug 26, 2019 |
Y-mAbs Therapeutics, Inc.
|
Director |
Sell |
51.3
|
-990
|
-0.15%
|
✗
|
$27.5K |
| Aug 20, 2019 |
Aug 26, 2019 |
Y-mAbs Therapeutics, Inc.
|
Director |
Sell |
17.5
|
-168,244
|
-2.88%
|
✗
|
$4.6M |
| Aug 20, 2019 |
Aug 22, 2019 |
Y-mAbs Therapeutics, Inc.
|
Director |
Sell |
17.5
|
-168,244
|
-2.56%
|
✗
|
$4.6M |